That research group went on to demonstrate that COX-2 causes upregulation of vascular endothelial growth factor C (VEGF-C) expression and encourages growth of new lymph vessels and subsequent lymph node metastasis [54]. The gene discussed is VEGFC; the disease is metastatic malignant neoplasm in the lymph nodes.